BIOTECNOLOGÍA DE NUTRACÉUTICOS Y COMPUESTOS BIOACTIVOS
BIONUC
Hospital Universitario Central de Asturias
Oviedo, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (26)
2024
-
A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma
eBioMedicine, Vol. 102
-
Draft genome sequence of Klebsiella pneumoniae KLEB-33: a convergent biofilm hyperforming multiresistant strain belonging to the emerging ST16 lineage harboring multiple hypervirulence genes
Microbiology Resource Announcements, Vol. 13, Núm. 4
-
Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies
Cell Communication and Signaling, Vol. 22, Núm. 1
2023
-
Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling
Biomedicine and Pharmacotherapy, Vol. 162
-
Cold plasma and inhibition of STAT3 selectively target tumorigenicity in osteosarcoma
Redox Biology, Vol. 62
-
Cold plasma-treated medium preferentially eliminates doxorubicin-resistant osteosarcoma cells
Free Radical Biology and Medicine, Vol. 209, pp. 127-134
-
Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer
Biomedicines, Vol. 11, Núm. 1
-
Reflections on the Biology of Cell Culture Models: Living on the Edge of Oxidative Metabolism in Cancer Cells
International Journal of Molecular Sciences, Vol. 24, Núm. 3
2022
-
Addressing Doxorubicin Resistance in Bone Sarcomas using Novel Drug‐Resistant Models
International Journal of Molecular Sciences, Vol. 23, Núm. 12
-
Cold atmospheric plasma enhances doxorubicin selectivity in metastasic bone cancer
Free Radical Biology and Medicine, Vol. 189, pp. 32-41
-
Proof of concept for the use of trained sniffer dogs to detect osteosarcoma
Scientific Reports, Vol. 12, Núm. 1
2021
-
Mithramycin delivery systems to develop effective therapies in sarcomas
Journal of Nanobiotechnology, Vol. 19, Núm. 1
2020
-
Melatonin-induced cytoskeleton reorganization leads to inhibition of melanoma cancer cell proliferation
International Journal of Molecular Sciences, Vol. 21, Núm. 2
2019
-
New chondrosarcoma cell lines with preserved stem cell properties to study the genomic drift during in vitro/in vivo growth
Journal of Clinical Medicine, Vol. 8, Núm. 4
-
The SRC inhibitor dasatinib induces stem cell-like properties in head and neck cancer cells that are effectively counteracted by the mithralog EC-8042
Journal of Clinical Medicine, Vol. 8, Núm. 8
-
The multikinase inhibitor EC-70124 synergistically increased the antitumor activity of doxorubicin in sarcomas
International Journal of Cancer, Vol. 145, Núm. 1, pp. 254-266
2018
-
FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway
Neoplasia (United States), Vol. 20, Núm. 1, pp. 44-56
-
GLUT1 protects prostate cancer cells from glucose deprivation-induced oxidative stress
Redox Biology, Vol. 17, pp. 112-127
-
Influence of inflammation in the process of T lymphocyte differentiation: Proliferative, metabolic, and oxidative changes
Frontiers in Immunology, Vol. 9, Núm. MAR
2017
-
Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models
Neoplasia (United States), Vol. 19, Núm. 6, pp. 460-470